Biomarker-Driven Computational PK/PD Modeling and Dosing Optimization of the Targeted Protein Degrader Fulvestrant in Estrogen Receptor–Positive Breast Cancer
Exposure-Safety Analyses of Talazoparib in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the TALAPRO-2 Trial
A QSP PDE Model of Adc Transport and Kinetics in Agrowing or Shrinking Tumor
Leveraging Large Language Models in Pharmacometrics: Evaluation of NONMEM Output Interpretation and Simulation Capabilities
An automated pipeline to generate initial estimates for population pharmacokinetic models
Quantifying natural amyloid plaque accumulation in the continuum of Alzheimer’s disease using ADNI
Model informed approach to estimate treatment effect in placebo- controlled clinical trials using an artificial intelligence based propensity weighting methodology to account for non-specific responses to treatment
Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly?
Whole-Body Physiologically-Based Pharmacokinetic Modeling of GalNAc conjugated siRNAs
Application of Model-informed Drug Development (MIDD) in Regulatory Submissions for Drug Approval in Japan
Learn more about Journal of Pharmacokinetics and Pharmacodynamics